Morgan Stanley
HTGM

Morgan Stanley’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-884
Closed -$2.39K 7844
2023
Q1
$2.39K Hold
884
﹤0.01% 7206
2022
Q4
$3.53K Sell
884
-9,727
-92% -$38.8K ﹤0.01% 7240
2022
Q3
$7K Buy
10,611
+588
+6% +$388 ﹤0.01% 7197
2022
Q2
$10K Sell
10,023
-4,740
-32% -$4.73K ﹤0.01% 7222
2022
Q1
$21K Buy
14,763
+11,933
+422% +$17K ﹤0.01% 7137
2021
Q4
$15K Sell
2,830
-1,389
-33% -$7.36K ﹤0.01% 7334
2021
Q3
$24K Sell
4,219
-27,449
-87% -$156K ﹤0.01% 7045
2021
Q2
$184K Buy
31,668
+30,279
+2,180% +$176K ﹤0.01% 6060
2021
Q1
$8K Sell
1,389
-1,383
-50% -$7.97K ﹤0.01% 7018
2020
Q4
$14K Sell
2,772
-48,726
-95% -$246K ﹤0.01% 6554
2020
Q3
$17K Buy
51,498
+13,658
+36% +$4.51K ﹤0.01% 6123
2020
Q2
$27K Buy
37,840
+35,092
+1,277% +$25K ﹤0.01% 5924
2020
Q1
$1K Sell
2,748
-451
-14% -$164 ﹤0.01% 6515
2019
Q4
$2K Buy
+3,199
New +$2K ﹤0.01% 6524
2019
Q2
Sell
-57,470
Closed -$144K 6817
2019
Q1
$144K Sell
57,470
-5,402
-9% -$13.5K ﹤0.01% 5223
2018
Q4
$160K Sell
62,872
-30,064
-32% -$76.5K ﹤0.01% 5371
2018
Q3
$470K Buy
92,936
+27,426
+42% +$139K ﹤0.01% 5038
2018
Q2
$213K Sell
65,510
-13,460
-17% -$43.8K ﹤0.01% 5509
2018
Q1
$286K Buy
78,970
+67,115
+566% +$243K ﹤0.01% 5310
2017
Q4
$24K Buy
11,855
+1,365
+13% +$2.76K ﹤0.01% 6030
2017
Q3
$18K Buy
10,490
+7,178
+217% +$12.3K ﹤0.01% 6051
2017
Q2
$9K Buy
+3,312
New +$9K ﹤0.01% 6268
2016
Q2
Sell
-12
Closed 6719
2016
Q1
$0 Hold
12
﹤0.01% 6785
2015
Q4
$0 Buy
+12
New ﹤0.01% 6855
2015
Q3
Sell
-1,886
Closed -$21K 6775
2015
Q2
$21K Buy
+1,886
New +$21K ﹤0.01% 6128